Document is current
Any future updates will be listed below
-
Authors
Vanderlinden, Greet https://orcid.org/0000-0002-5673-4121
Radwan, Ahmed
Christiaens, Daan
Blommaert, Jeroen
Sunaert, Stefan
Vandenbulcke, Mathieu
Koole, Michel
Van Laere, Koen
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (FWO/G093218N)
KU Leuven C2 funding (C24-17-063)
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 6 March 2025
First Online: 5 April 2025
Declarations
:
: The study was approved by the local Ethics Committee UZ/KU Leuven and was conducted according to the latest version of the Declaration of Helsinki. Written informed consent was signed by all participants prior to study inclusion.
: Not applicable.
: K.V.L. performed this study as senior investigator of FWO Flanders. K.V.L. is an advisory board member of Cerveau-Lantheus and has received fees through KU Leuven for consultancy activities for GE Healthcare. K.V.L. and M.K. have performed contract research through KU Leuven for Merck, Janssen Pharmaceuticals, UCB, Syndesi, Eikonizo, GE Healthcare, Cerevel, BMS and Curasen. No other potential conflicts of interest relevant to this article exist.
